Radiation therapy for duct carcinoma in situ. Who needs radiation therapy, who doesn't? Journal Article
| Author: | McCormick, B. |
| Article Title: | Radiation therapy for duct carcinoma in situ. Who needs radiation therapy, who doesn't? |
| Abstract: | Duct carcinoma in situ (DCIS) is a common but non-life-threatening breast cancer. Four large prospective randomized trials comparing radiation therapy (RT) with none after breast-conservation surgery have all concluded that the use of RT reduces the risk of a local recurrence (LR) in the ipsilateral breast by at least 50%. More information is needed to assess the role of antiestrogen therapy when RT is not given. When markers are validated to predict which patients will have an invasive LR versus another DCIS or no LR, it is hoped that the discussion with the patient will clarify the situation further. © 2013 Elsevier Inc. |
| Keywords: | breast cancer; radiation therapy; dcis; duct carcinoma in situ |
| Journal Title: | Hematology/Oncology Clinics of North America |
| Volume: | 27 |
| Issue: | 4 |
| ISSN: | 0889-8588 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-08-01 |
| Start Page: | 673 |
| End Page: | 686 |
| Language: | English |
| DOI: | 10.1016/j.hoc.2013.05.001 |
| PROVIDER: | scopus |
| PUBMED: | 23915738 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 4 September 2013" - "CODEN: HCNAE" - "Source: Scopus" |
